BOD Australia Ltd
ASX:BOD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
BOD Australia Ltd
Cash from Investing Activities
BOD Australia Ltd
Cash from Investing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
BOD Australia Ltd
ASX:BOD
|
Cash from Investing Activities
-AU$275k
|
CAGR 3-Years
-10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Cash from Investing Activities
AU$559.8k
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Cash from Investing Activities
-AU$68.1m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Cash from Investing Activities
-AU$88m
|
CAGR 3-Years
-1 567%
|
CAGR 5-Years
-581%
|
CAGR 10-Years
N/A
|
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Cash from Investing Activities
AU$52m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vita Life Sciences Ltd
ASX:VLS
|
Cash from Investing Activities
-AU$570k
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
4%
|
|
BOD Australia Ltd
Glance View
Bod Australia Ltd. operates as a developer, manufacturer, distributor, importer, exporter and marketer of skincare, beauty, and health industries for the natural segment of the market. The company is headquartered in Sydney, New South Wales. The company went IPO on 2016-10-27. The firm is engaged in the development and manufacture of cannabidiol (CBD) and hemp products for consumer markets in Australia and United Kingdom, as well as the development, manufacture and distribution of therapeutics medicinal cannabis products. The firm operates through three segments: medical, over the counter cannabidiol/Hemp (OTC CBD/Hemp) and OTC Herbals.
See Also
What is BOD Australia Ltd's Cash from Investing Activities?
Cash from Investing Activities
-275k
AUD
Based on the financial report for Jun 30, 2025, BOD Australia Ltd's Cash from Investing Activities amounts to -275k AUD.
What is BOD Australia Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
10%
Over the last year, the Cash from Investing Activities growth was 86%. The average annual Cash from Investing Activities growth rates for BOD Australia Ltd have been -10% over the past three years , 10% over the past five years .
